Save the Cord Foundation and WellSky are proud to welcome Dr. Maegan Capitano, as our featured speaker for our next edition of Share the Science on Tuesday, April 12th, 2022 2pm ET / 11am PT. Join us to hear Dr. Capitano discuss her latest research published in co-operation with the late Dr. Hal Broxmeyer, focused on the ideal conditions for collecting and processing cord blood for transplant. Recording now available. Register here. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here. How does temperature affect cord blood transplants? It starts at birth.A special Share the Science, honouring the late Dr. Hal Broxmeyer and his final contributions to cord blood research, led by his colleague and protégé, Dr. Maegan Capitano.
SHARE THE SCIENCE with Maegan L. Capitano, BA, MS, PhD Assistant Professor of Microbiology & Immunology, Indiana University School of Medicine "Impact of Temperature on Cord Blood Transplant Efficacy" Free webinar. Open to the public. Tuesday, April 12 at 2 pm ET / 11 am PT RECORDING NOW AVAILABLE - WATCH HERE About the speaker
We wish to thank Dr. Maegan Capitano for volunteering her time to speak on
Share the Science and sharing her valuable insight on the efficient collection and processing of cord blood. We also wish to also thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series.
Save the Cord Foundation and WellSky are proud to welcome Dr. John Wagner, as our featured speaker for our next edition of Share the Science on July 22nd, 2021 2pm ET / 11am PT. Join us to hear Dr. Wagner discuss his research using umbilical cord blood-derived regulatory T Cells (Tregs) to combat Graft versus Host Disease (GvHD). RECORDING NOW AVAILABLE. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here. Preventing GvHD with Regulatory T Cells (Tregs)Join us to hear pioneering researcher John Wagner, M.D. as he shares some of his latest work involving potential treatment of autoimmunity and graft-versus-host disease (GVHD). Infection and relapse are the principal obstacles to successful use of allogeneic hematopoietic stem cell transplantation. Prolonged immunodeficiency is a major cause of infection and relapse, particularly in those with high-risk disease, older age, use of in vivo and ex vivo T cell depletion, HLA mismatch, and after the development of acute and chronic GVHD. Trials have demonstrated that the infusion of umbilical cord blood (UCB) derived regulatory T cells (Tregs) could effectively prevent GVHD. Join Dr. Wagner as he also shares how thymic progenitor cells (Pro-Ts) can repair damaged immune systems, and how UCB can reliably provide large numbers of Pro-Ts suitable for clinical use. SHARE THE SCIENCE with John Wagner, M.D. Founding Director of the Institute of Cell, Gene and Immunotherapeutics at the University of Minnesota "Combatting GVHD with UCB-derived regulatory T cells" Free webinar. Open to the public. Thursday, July 22nd at 2 pm ET / 11am PT RECORDING NOW AVAILABLE About the speaker
We wish to thank Dr. John Wagner for volunteering his time to speak on
Share the Science and sharing his valuable insight on the use of cord blood-derived Tcells (Tregs) to combat GvHD. We also wish to also thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2025
Categories |